Agree moosey and jev, I think there are a few disgruntled...

Agree moosey and jev,

I think there are a few disgruntled shareholders showing signs of frustration and that's fine but this is the way with health/biotech sector, things take time.

You cannot expect large movements in SP when the transition from discovery/trials/approvals to commercialisation is in the early stages. This company is rolling out one of it's many products globally and this will take time to implement successfully and I like their linear approach and vertical intergration of the BTM.

The reason I am invested here is the magnitude and diversity of the pipeline of real world changing products Polynovo will roll out in the not to distant future. This is not a short term play obviously so it may take a little patience but the products cannot be in dispute, this in mine will be a multi dollar share and that's why it's a no brainer.